Skip to main content
Saudi Pharmaceutical Journal : SPJ logoLink to Saudi Pharmaceutical Journal : SPJ
. 2021 May 1;29(7):682–691. doi: 10.1016/j.jsps.2021.04.030

Characteristics and outcome of COVID-19 cases in Saudi Arabia: Review of six-months of data (March–August 2020)

Fahad M Alswaidi 1,, Abdullah M Assiri 1, Haya H Alhaqbani 1, Mohrah M Alalawi 1
PMCID: PMC8347652  PMID: 34400862

Abstract

Background

This study presents the demographic, epidemiological, and clinical characteristics of Coronavirus Disease 2019 (COVID-19) in Saudi Arabia (KSA). It identifies the important predictors of the disease prognosis.

Methods

The study reviewed and analysed a sample of 307,010 confirmed symptomatic COVID-19 cases, between March and August 2020, available in the health electronic surveillance system (HESN) of the Ministry of Health of KSA. Descriptive and univariate analyses were conducted.

Results

The overall estimated prevalence of symptomatic COVID-19 cases in KSA between March and August 2020 was 6.1% . The estimated incidence proportion was 879.7 per 100,000 population. The overall case fatality ratio was 2.0%. Males represented 63.9% , with a mean age of 35.1 ± 16.6 years. Young adults (16–39 years) were the most affected ages (53.3%). Fever (90.5%) with a mean body temperature of 37.4 ± 2.0 Celsius, cough (90%), and sore throat (77.4%) were the most prevalent symptoms. A history of contact with a confirmed COVID-19 case was reported in 98.8% of patients.

Males (2.1%) and elderly cases aged 65–99 years (25.6%) had the highest association with mortality (p < .001). Among the clinical characteristics investigated, low oxygen saturation (SpO2 ≤ 93%) had the highest association with hospital admission (50.8%) and mortality (19.1%) (p < .001). Cases with cardiovascular diseases (28.6%) and malignancy (28%) demonstrated the highest associations with mortality compared to other underlying diseases (p < .001).

Conclusions

In KSA, the prevalent symptoms of COVID-19 are fever, cough, and sore throat. Makkah and Almadinah regions are significantly associated with highest burden of mortality. The low level of oxygen saturation, high fever, old age, and underlying cardiovascular disease are the most important predictors for prognosis.

Keywords: COVID-19, Demographic features, Clinical and epidemiological characteristics, Saudi Arabia

Abbreviations

CDC

Centres for Disease Control and Prevention

CFR

Case fatality ratio

COVID-19

Coronavirus Disease 2019

HESN

Health electronic surveillance network

ICU

Intensive care unit

IRB

Institutional Review Board

KSA

Saudi Arabia

MERS-CoV

Middle East respiratory syndrome coronavirus

PCR

Polymerase chain reaction

p-value

Probability value

SARS-COV1

Severe acute respiratory syndrome coronavirus 1

SpO2

Peripheral blood oxygen saturation

SPSS

Statistical Package for Social Sciences

UK

United Kingdom

WHO

World Health Organization

1. Introduction

Since December 2019, the emerging coronavirus disease, COVID-19, has spread worldwide, causing over 80 million cases and over one million deaths in>190 countries (Johns Hopkins University, 2020). As of November 2020, there have been over 300,000 cases of COVID-19 in Saudi Arabia (KSA), with over 5000 deaths. While the exact mechanisms of COVID-19 transmission are under continuing investigation, it is thought to primarily spread from person to person through airborne respiratory droplets produced when an infected person coughs, sneezes, or talks (Hossain et al., 2020, Harmooshi et al., 2020). Infection is transmitted by symptomatic patients, but transmission can also occur from asymptomatic individuals and before symptom onset (Singhal, 2020). The transmission of COVID-19 is propagative and its trend is affected by the implemented preventive measures like majority of viruses. At the early stages of the epidemic in KSA, Youssef et al., 2020a, Youssef et al., 2020b could apply the modified Susceptible-Exposed-Infectious-Recovered (SEIR) statistical model and successfully predicted that the number of COVID-19 cases would decrease to >500 per day by the beginning of October 2020. Moreover, this model could statistically prove that prevention is better than cure and isolation of infected people is essential to control the epidemic.

The novelty of the virus, the rapid national and international spread, the lack of therapeutic and preventative strategies, and its ability to paralyse health systems worldwide led the World Health Organization (WHO) to declare the disease a Public Health Emergency of International Concern on January 30, 2020 (Al-Tawfiq and Memish, 2020). To limit spread, many countries, including KSA, implemented preventive measurements of varying degrees. The first confirmed case of COVID-19 was reported by the Saudi MoH on March 2, 2020 from ALQatif region, where lockdown was enforced, all community gathering was prohibited, and recommendations of social precautions such as social distancing, hand hygiene, and wearing a mask were made. With the gradual spread of the disease, several congregational events were cancelled, and travel was limited. For the first time in the history of the annual Muslim pilgrimage, KSA restricted visitors from abroad from performing Hajj (Al-Tawfiq and Memish, 2020, Alkhowailed et al., 2020). While research of COVID-19 in KSA has been conducted, these studies were based on limited sample sizes and lacked important information on the outcome of COVID-19 (Alsofayan et al., 2020, Jdaitawi et al., 2020, Almaghlouth et al., 2020). The clinical characteristics of 1519 COVID-19 cases in KSA reported that cough, fever, and sore throat were the most common symptoms. Around 71% of the cases were admitted to hospital while 4.7% admitted to ICU (Alsofayan et al., 2020). Understanding the clinical behaviour of the disease and its epidemiology is crucial to establishing the appropriate policies and guidelines to control the epidemic. Therefore, this study used the largest available sample of confirmed COVID-19 cases in KSA from March 2 to August 31, 2020 to investigate their clinical and epidemiological characteristics and to estimate the dynamics of COVID-19 during this period. This study aimed to evaluate the magnitude and distribution of COVID-19 cases in KSA, determine the demographic, clinical, and epidemiological characteristics of the COVID-19 cases, and examine the relationship between these characteristics with hospital admission and death.

2. Materials and methods

2.1. Study design and data collection

This was a descriptive quantitative study of all available data of COVID-19 cases obtained from the HESN database between March and August 2020. Data originally belong to main laboratories and blood banks, regional health directorates, and all hospitals (governmental and private sector). The total number of COVID-19 tests administered was based on the KSA health reports for March to August 2020 (COVID-19 dashboard, Saudi Arabia, 2020)).

2.2. Ethics approval

Identities of all cases remained anonymous throughout all stages of the study. Central IRB approval (No: 20–199 M) was granted on 02/11/2020.

2.3. Data analysis

Data extracted from the HESN was cleaned by removing duplicates, cases from outside the specified date range, and entry errors. A COVID-19 case was defined as any individual in the dataset who tested positive for COVID-19 infection using a polymerase chain reaction (PCR) test and only these positive cases were included in analysis. Any cases with missing values were excluded. SPSS & Microsoft Excel software were used for data analysis.

Frequency and percentage were calculated for all variables in addition to mean and standard deviation for continuous variables. Incidence proportion, case fatality ratio (CFR) and mortality rate were calculated using the following formulae (CDC, 2008):

Incidence proportion: Number of new cases of COVID-19 during the given time period/the average population (×10n).

Mortality rate: Number of deaths attributed to COVID-19 during the given time period/the average population (×10n).

CFR: Total number of new deaths due to COVID-19/the total number of patients with COVID-19 (×10n).

Categorical data of independent variables were compared and tested against the identified dependent variables (outcomes) using univariate analysis with Chi square as measure of association and significance level at p < 0.05.

3. Results

3.1. Magnitude and distribution of COVID-19 cases

As of August 31, 2020, 5,063,693 COVID-19 PCR tests had been administered in KSA, (COVID-19 dashboard, Saudi Arabia, 2020) with an overall estimated prevalence of COVID-19 of 15.8%, with a prevalence of symptomatic COVID-19 cases of 6.1%. The total number of confirmed symptomatic COVID-19 cases was 307,010 (47.3% of all positive cases), with an incidence proportion of 879.7 per 100,000 national population. The overall death rate among symptomatic COVID-19 cases was 2.0%, while the overall CFR was estimated as 0.8%. Makkah and Almadina regions registered the highest CFR (2.1% each), followed by the Northern Borders region (0.8%; Table 1).

Table 1.

Distribution of COVID-19 confirmed cases and their outcome by Saudi administrative regions, March-August 2020.

Region 1Population Confirmed cases (N = 649,511)
2Incidence proportion
Outcome (N = 117,299)
3CFR
Symptomatic
Symptomatic
Yes % No % Yes No Recovered % Dead %
Riyadh 8,771,918 69,174 22.5 69,967 20.4 788.5 797.6 24,706 21.5 351 14.9 0.5
Eastern 5,271,050 73,018 23.8 65,387 19.1 1385.2 1240.4 26,002 22.6 122 5.2 0.2
Makkah 8,990,579 72,387 23.6 78,806 23.0 805.1 876.5 42,186 36.7 1514 64.3 2.1
AlMadina 2,280,945 12,846 4.2 17,697 5.2 563.2 775.8 12,342 10.7 275 11.7 2.1
AlQassim 1,550,080 18,706 6.1 10,672 3.1 1206.7 688.4 1833 1.6 18 0.8 0.1
Tabouk 1,000,609 3,869 1.3 9,739 2.8 386.6 973.30 2531 2.2 17 0.7 0.4
Hail 756,611 5,878 1.9 6,719 2.0 766.8 888.03 1073 0.9 14 0.6 0.2
Northern Borders 405,119 1,444 0.5 4,122 1.2 356.4 1017.4 528 0.5 11 0.5 0.8
Jazan 1,730,961 14,644 4.8 17,785 5.2 846.0 1027.4 1166 1.0 16 0.7 0.1
Najran 642,205 6,018 2.0 6,672 1.9 937.0 1038.9 675 0.6 3 0.1 0.0
AlBahah 519,994 3,244 1.1 5,798 1.7 623.9 1115.0 605 0.5 5 0.2 0.2
AlJouf 558,995 712 0.2 3,843 1.1 127.4 687.4 160 0.1 1 0.0 0.1
Assir 2,419,896 25,070 8.2 45,294 13.2 1036.0 1871.7 1136 1.0 9 0.4 0.0
Total 34,898,962 307,010
(47.3%)
100.0 342,501
(52.7%)
100.0 879.7 981.4 114,943
(98.0%)
100.0 2,356
(2.0%)
100.0 0.8
1

Saudi General Authority for Statistics. The sixteenth guide 2017. [cited 2020 Oct 15]. Available from: https://www.stats.gov.sa/en/825.

2

Incidence proportion = Symptomatic no/Population no * 100,000

3

Case fatality ratio (CFR) = Dead no/ٍSymptomatic no * 100

The epidemic curve demonstrates a propagative distribution of symptomatic cases (Fig. 1). On May 25, 2020, the number of cases tripled from the previous day and continued to increase until a peak on July 7, 2020. From that overall peak to the end of August, there was continuous decrease in the number of new cases, with weekly peaks.

Fig. 1.

Fig. 1

Epidemic curve of new symptomatic COVID-19 cases in Saudi Arabia between March 1 and August 31, 2020.

3.2. Demographic characteristics

Most COVID-19 cases (mean age 35.1 ± 16.6 years) were youth and young adults (16–39 years, 53.3% of all cases) followed by middle age (40–64 years, 30.8%). Cases in older adults (≥100 years) registered the lowest proportion (0.1%; Table 2). Males represented 63.9% of all cases.

Table 2.

Demographic characteristics of the COVID-19 confirmed cases in Saudi Arabia, March-August 2020 (N = 799,184).

Variable Number %
Age:
0-1
2-5
6-15
16-39
40-64
65-99
≥100

Total




12,413
20,182
55,088
425,786
246,424
38,520
334
798,747




1.6
2.5
6.9
53.3
30.8
4.8
0.1
100
Mean
SD
35.12
16.61
Gender:
Male
Female
Total

510,741
288,291
799,032

63.9
36.1
100
Nationality:
Saudi
Arab
Non-Arab
Total

500,361
103,482
188,846
792,689

63.1
13.1
23.8
100
Occupation:
Healthcare workers
Governmental
Private sector
Freelancers
Unemployed
Unknown
Total

27,806
77,933
121,634
54,007
367,437
150,367
799,184

3.5
9.8
15.2
6.8
46.0
18.8
100
Healthcare Workers department:
ER
ICU
OR
OPD
Other
Total

466
78
15
122
1155
1836

25.4
4.2
0.8
6.6
62.9
100
Region:
Riyadh
Makkah
AlMadina
AlQassim
Eastern
Tabouk
Hail
Northern Borders
Jazan
Najran
AlBahah
AlJouf
Asir
Total

187,234
193,673
44,247
33,979
168,619
15,210
15,530
6340
33,877
13,027
9421
5755
72,192
799,104

23.4
24.2
5.5
4.3
21.1
1.9
1.9
0.8
4.2
1.6
1.2
0.7
9.0
100
Top 10 nationalities infected:
Saudi Arabia
India
Bangladesh
Egypt
Yemen
Pakistan
Philippines
Sudan
Syrian Arab Republic
Nepal

500,361
59,489
40,676
37,585
31,824
25,228
23,851
15,105
9141
7612

63.1
7.4
5.1
4.7
4.0
3.2
3.0
1.9
1.1
1.0
Deaths by nationality (N = 2,356):
Saudi Arabia
Bangladesh
Yemen
Pakistan
India
Myanmar
Philippines
Egypt
Sudan
Afghanistan
Syrian Arab Republic
Nigeria
Others

626
364
222
186
183
165
75
69
69
45
33
26
293

26.6
15.4
9.4
7.9
7.8
7.0
3.2
2.9
2.9
1.9
1.4
1.1
12.4

The nationalities among COVID-19 cases represented >170 countries/territories, with the majority from KSA (63.1%), followed by India (7.4%), Bangladesh (5.1%), and Egypt (4.7%). The nationalities among cases of death attributed to COVID-19, included Saudis (26.6%), Bangladeshis (15.4%) and Yemenis (9.4%).

3.3. Clinical and epidemiological characteristics of symptomatic cases

Among COVID-19 cases, 47.3% were symptomatic, however only 13.0% required hospitalization, with an overall death rate of 2.0% (Table 3). Fever was the most prominent symptom (90.5%) followed by cough (90.0%) and sore throat (77.4%). Only 13.9% of patients with fever presented with temperature >38 °C (mean 37.4 ± 2.0 °C). Tachypnoeic patients with a mean respiratory rate of 21.4 ± 11.0 breaths/minute represented only 1.8% of cases. Oxygen saturation (SpO2) ≤ 93% was reported in 8.7% of the symptomatic patients (mean 93.5 ± 6.3%). Among symptomatic cases, 11.6% were diagnosed with pneumonia, among which 19.7% had a severity score of ≥3. The average disease course between symptom onset and recovery was 19.4 ± 13.9 days, and 9.1 ± 8.6 days from diagnosis to death. Most positive cases (98.8%) reported a history of contact with a confirmed COVID-19 case (Table 3).

Table 3.

Clinical and epidemiological characteristics of the COVID-19 confirmed cases in Saudi Arabia, March-August 2020.

Variable No %
Signs & symptoms:
Yes
No
Total

307,010
342,508
649,518

47.3
52.7
100
Fever:
Yes
No
Total

137,915
14,557
152,472

90.5
9.5
100
Temperature (°C):
37–38
38.1–39>
39
Total
Mean 37.4
SD 2.0

176,761
25,310
3238
205,309

86.1
12.3
1.6
100
Cough:
Yes
No
Total

117,005
13,022
130,027

90.0
10.0
100
Sore throat:
Yes
No
Total

44,009
12,830
56,839

77.4
22.6
100
Runny nose:
Yes
No
Total

18,830
12,358
31,188

60.4
39.6
100
Respiratory rate (breath/minute):
≤ 26>
26
Total
Mean 21.4
SD 11.0

37,632
695
38,327

98.2
1.8
100.0
Oxygen saturation; SpO2 (%):
≤ 93>
93
Total
Mean 93.5
SD 6.3

4762
50,221
54,983

8.7
91.3
100
Pneumonia:
Yes
No
Total

35,497
271,513
307,010

11.6
88.4
100
Severity score of pneumonia:
> 3
≤ 3
Total

28,497
6,970
35,467

80.3
19.7
100
Hospital admission:
Yes
No
Total

34,554
230,823
265,377

13.0
87.0
100
Length of disease course until Recovery (Days)1:
1–7
8–15
16–30
31–90
< 91
Total
Mean 19.42
SD 13.93


1935
57,902
35,182
11,065
1401
107,485


1.8
53.9
32.7
10.3
1.3
100
Length of disease course until Death (Days)2:
1–7
8–15
16–30
31–90
Total
Mean 9.11
SD 8.61


154
138
55
13
360


42.8
38.3
15.3
3.6
100
Contacted confirmed case:
Yes
No
Total

117,185
1390
118,575

98.8
1.2
100
Travel outside KSA:
Yes
No
Total

869
74,724
75,593

1.1
98.9
100
Travel inside KSA:
Yes
No
Total

12,500
252,857
265,357

4.7
95.3
100
Outcome
Final outcome:
Recovered
Dead
Total

114,946
2356
117,302

98.0
2.0
100
1

From the date of symptom onset to 3 days after fever subsided or PCR result was negative.

2

From the date of symptom onset to death declaration.

Hospital admissions for COVID-19 were the highest in the regions of Riyadh (46.0%) followed by Makkah (21.4%), and Najran region has the lowest rate of hospitalization (0.5%). The highest proportion of hospital admissions occurred in May (28.9%) and the lowest was in March (2.6%).

3.4. Relationship between demographic factors and symptoms of COVID-19

Among COVID-19 cases, symptoms were more likely to appear in males (48.2%) than females (45.7%). The eldest group (>100 years) had the highest rate of symptomatic cases (60.9%) compared to all other age groups. Individuals from KSA had the highest rate of symptomatic cases (55.5%) compared to any other nationality. Individuals from Alqassim region reported the highest rate of symptomatic cases (63.7%) than other regions. Finally, those who are privately employed had the highest rate of cases with symptoms (54.0%) followed by healthcare workers (53.8%; P > .001) (Table 4).

Table 4.

Association of demographic factors with symptoms and outcome of COVID-19 cases in Saudi Arabia, March-August 2020.

Symptomatic
Outcome
Gender Yes % No % Total X2 df p-value Dead % Recovered % Total X2 df p-value
Male 195,217 48.2 209,763 51.8 404,980 378.3 1 0.001 1858 2.1 87,411 97.9 89,269 9.9 1 0.002
Female 111,758 45.7 132,698 54.3 244,456 498 1.8 27,504 98.2 28,002
Total 306,975 47.3 342,461 52.7 649,436 2356 2.0 114,915 98.0 117,271
Age group
0–1 4967 49.8 5000 50.2 9967 5577.3 6 0.001 5 0.3 1478 99.7 1483 6605.4 6 0.001
2–5 6437 38.5 10,273 61.5 16,710 6 0.2 2494 99.8 2500
6–15 16,857 35.6 30,432 64.4 47,289 2 0.0 6393 100 6395
16–39 160,125 46.1 187,211 53.9 347,336 236 0.4 63,650 99.6 63,886
40–64 101,054 51.3 95,766 48.7 196,820 1379 3.6 37,461 96.4 38,840
65–99 17,237 56.1 13,506 43.9 30,743 718 17.4 3408 82.6 4126
≥100 159 60.9 102 39.1 261 10 25.6 29 74.4 39
Total 306,836 47.3 342,290 52.7 649,126 2356 2.0 114,913 98.0 117,269
Nationality
Saudi 190,550 44.4 238,892 55.6 429,438 4630.6 2 0.001 626 1.4 42,621 98.6 43,247 111.5 2 0.001
Arabs 47,834 55.5 38,422 44.5 82,987 450 2.5 17,821 97.5 18,271
Non-Arabs 68,626 51.3 65,194 48.7 133,665 1280 2.3 54,504 97.7 55,784
Total 307,010 47.3 342,508 52.7 646,090 2356 2.0 114,946 98.0 117,302
Region
Riyadh 69,040 50.0 69,135 50.0 138,175 15171.2 12 0.001 351 1.4 24,706 98.6 25,057 906.8 12 0.001
AlBahah 3244 35.9 5798 64.1 9042 5 0.8 605 99.2 610
AlJouf 846 15.3 4675 84.7 5521 1 0.6 160 99.4 161
AlMadina 12,846 42.1 17,697 57.9 30,543 275 2.2 12,342 97.8 12,617
AlQassim 18,706 63.7 10,672 36.3 29,378 18 1.0 1833 99.0 1851
Makkah 72,387 47.9 78,806 52.1 151,193 1517 3.5 42,183 96.5 43,700
Asir 25,070 35.6 45,294 64.4 70,364 9 0.8 1136 99.2 1145
Eastern 73,018 52.8 65,387 47.2 138,405 122 0.5 26,002 99.5 26,124
Hail 5878 46.7 6719 53.3 12,597 14 1.3 1073 98.7 1087
Jazan 14,644 45.2 17,785 54.8 32,429 16 1.4 1166 98.6 1182
Najran 6018 47.4 6672 52.6 12,690 0 0.0 678 100 678
Northern Borders 1444 25.9 4122 74.1 5566 11 2.0 528 98.0 539
Tabouk 3869 28.4 9739 71.6 13,608 17 0.7 2531 99.3 2548
Total 307,010 47.3 342,501 52.7 649,511 2356 2.0 114,943 98.0 117,299
Occupation
Governmental 35,261 45.3 42,648 54.7 77,909 4404.7 4 0.001 15 0.5 2817 99.5 2832 91.7 4 0.001
Private sector 65,617 54.0 55,899 46.0 121,516 129 1.3 9554 98.7 9683
Freelancers 27,689 51.3 26,278 48.7 53,967 76 2.3 3241 97.7 3317
Healthcare workers 14,946 53.8 12,832 46.2 27,778 10 0.5 2048 99.5 2058
Unemployed 162,975 44.4 204,361 55.6 367,336 361 2.4 14,822 97.6 15,183
Total 306,488 47.3 342,018 52.7 648,506 591 1.8 32,482 98.2 33,073
Healthcare Workers department
ER 133 28.5 333 71.5 466 14.3 4 0.006 11 4.1 269 95.9 280 2.785 4 0.594
ICU 27 34.6 51 65.4 78 3 9.7 28 90.3 31
OR 4 26.6 11 73.3 15 0 0 3 100.0 3
OPD 55 85.1 67 54.9 122 2 4.1 47 95.9 49
Other 411 35.6 744 64.4 1155 18 3.7 462 96.3 480
Total 630 34.3 1206 65.7 1836 34 4.0 809 96.0 843
Non-Saudi Nationalities
Bangladesh 13,082 49.5 13,370 50.5 26,452 853.2 11 0.001 364 2.5 14,256 97.5 14,620 612.9 11 0.001
Yemen 14,572 54.5 12,180 45.5 26,752 222 4.1 5237 95.9 5459
Pakistan 9025 51.7 8418 48.3 17,443 186 2.4 7468 97.6 7654
India 22,973 54.8 18,979 45.2 41,952 183 1.1 17,056 98.9 17,239
Myanmar 827 54.4 694 45.6 1521 165 7.1 2143 92.9 2308
Philippines 9101 52.6 8215 47.4 17,316 75 1.6 4525 98.4 4600
Egypt 16,789 57.2 12,586 42.8 29,375 69 0.9 7446 99.1 7515
Sudan 6579 53.5 5727 46.5 12,306 69 3.1 2184 96.9 2253
Afghanistan 1592 52.9 1419 47.1 3011 45 4.7 907 95.3 952
Syria 4341 57.7 3184 42.3 7525 33 2.7 1189 97.3 1222
Nigeria 290 38.1 472 61.9 762 26 9.3 254 90.7 280
Others 17,291 48.5 18,374 51.5 35,665 293 2.9 9660 97.1 9953
Total 116,462 52.9 103,618 47.1 220,080 1730 2.3 72,325 97.7 74,055

3.5. Relationship between demographic factors and the outcome of COVID-19

Among COVID-19 cases, males had a greater incidence of death (2.1%) than females (1.8%). The eldest cases (>100 years) had the highest rate of death (25.6%). Generally, Arab nationalities reported the highest rate of death (2.5%) compared to other nationalities. However, among all non-Saudi nationalities, Nigerians had the highest rate of death (9.3%) and Egyptians had the least rate of death from COVID-19 (P > .001) (Table 4).

3.6. Relationship between demographic factors and hospital admission

A greater proportion of male COVID-19 patients (14.0%) were admitted to hospital than female (10.9%). Older adult patients (65–99 years) has the highest rate of hospitalization (29.4%) while the adolescents group (6–15 years) had the lowest hospital admission rate (5.6%). Among COVID-19 cases from the Northern Borders region, 56.0% required hospital admission, while only 2.6% of cases in Asir region required hospital admission. Freelancers with COVID-19 were more likely to be admitted to the hospital compared to any other occupations. Generally, cases of COVID-19 of non-Arab nationalities had the highest rate of hospital admission (18.1%) compared to other nationalities. Among non-Saudi nationalities, individuals from Myanmar were associated with the highest rate of hospital admission (33.1%), and the lowest rate was reported among the Sudanese (15.3%; P > .001) (Table 5).

Table 5.

The effect of demographic factors on hospital admission of COVID-19 cases in Saudi Arabia, March-August 2020.

Hospital Admission
Gender Yes % No % Total X2 df p-value
Male 25,080 14.0 153,686 86.0 178,766 500.0 2 0.001
Female 9462 10.9 77,100 89.1 86,562
Total 34,553 13.0 230,819 87.0 265,372
Age group
0–1 448 10.2 3936 89.8 4384 8315.2 6 0.001
2–5 347 5.9 5528 94.1 5875
6–15 794 5.6 13,439 94.4 14,233
16–39 12,160 9.1 121,753 90.9 133,913
40–64 16,202 17.8 75,070 82.2 91,272
65–99 4557 29.4 10,947 70.6 15,504
≥100 33 25.0 99 75.0 132
Total 34,541 13.0 230,772 87.0 265,313
Nationality
Saudi 12,845 9.0 129,278 91.0 142,123 4337.0 2 0.001
Arab 7197 16.7 35,951 83.3 43,148
Non-Arab 14,512 18.1 65,594 81.9 80,106
Total 34,554 13.0 230,823 87.0 265,377
Region
Riyadh 7408 10.6 62,687 89.4 70,095 11992.7 12 0.001
AlBahah 222 37.7 367 62.3 589
AlJouf 276 33.7 543 66.3 819
AlMadina 2285 24.8 6919 75.2 9204
AlQassim 1514 12.9 10,199 87.1 11,713
Makkah 15,888 19.2 67,004 80.8 82,892
Asir 857 2.6 32,026 97.4 32,883
Eastern 3734 7.8 44,329 92.2 48,063
Hail 448 19.0 1908 81.0 2356
Jazan 470 27.6 1233 72.4 1703
Najran 167 14.8 964 85.2 1131
Northern Borders 778 56.0 612 44.0 1390
Tabouk 507 20.3 1987 79.7 2494
Total 34,554 13.0 230,778 87.0 265,332
Occupation
Governmental 776 4.4 16,758 95.6 17,534 714.8 4 0.001
Private sector 4519 10.0 40,531 90.0 45,050
freelancers 1855 11.8 13,808 88.2 15,663
Healthcare workers 771 7.7 9201 92.3 9972
Unemployed 9655 10.1 85,543 89.9 95,198
Total 17,576 9.6 165,841 90.4 183,417
Non-Saudi nationalities
Bangladesh 3564 21.6 12,965 78.4 16,529 5157.4 11 0.001
Yemen 2096 17.7 9768 82.3 11,864
Pakistan 2398 22.0 8518 78.0 10,916
India 4057 15.7 21,788 84.3 25,845
Myanmar 516 33.1 1045 66.9 1561
Philippines 1550 14.7 9009 85.3 10,559
Egypt 2601 15.9 13,733 84.1 16,334
Sudan 930 15.3 5154 84.7 6084
Afghanistan 416 32.9 848 67.1 1264
Syria 746 20.8 2846 79.2 3592
Nigeria 74 23.3 243 76.7 317
Others 15,606 9.7 144,906 90.3 160,512
Total 34,554 13.0 230,823 87.0 265,377

3.7. Relationship between signs and symptoms and hospital admission

Cases with fever were associated with higher rate of hospital admission (17.9%) compared to those without fever, with those who had a temperature of >39 Celsius having the highest rate of hospital admission (30.1%). Cases with low oxygen saturation (SpO2 ≤ 93%) had a higher rate of hospital admission (50.8%) compared to cases with SpO2 > 93%. Patients who had a respiratory rate 26 <  were associated with a higher rate of hospital admission (34.8%) than patients with lower respiratory rates. Patients with pneumonia were associated with greater hospital admission rates (17.5%) than those without pneumonia. Among them, patients with a pneumonia severity score ≥ 3 had the highest rate of hospital admission (28.6%) than patients with the lower pneumonia severity score (P > .001) (Table 6).

Table 6.

Association of symptoms with the hospital admission and outcome of COVID-19 cases, March-August 2020.

Hospital Admission
Outcome
Fever Yes % No % Total X2 df p-value Dead % Recovered % Total X2 df p-value
Yes 20518 17.9 94131 82.1 114649 466.9 1 .001 1325 4.3 29456 95.7 30781 221.4 1 .001
No 722 8.6 7633 91.4 8355 25 0.4 6132 99.6 6157
Total 21240 17.3 101764 82.7 123004 1350 3.7 35588 96.3 36938
Temperature °C
37–38 22818 12.9 153931 87.1 176749 1238.4 2 .001 1387 3.2 41423 96.8 42810 81.6 2 .001
38.1–39 4587 18.1 20722 81.9 25309 322 5.2 5856 94.8 6178
>39 975 30.1 2262 69.9 3237 61 6.1 931 93.9 992
Total 28380 13.8 176915 86.2 205295 1770 3.5 48210 96.5 49980
Cough
Yes 18873 19.0 80436 81.0 99309 482.2 1 .001 1294 4.3 28623 95.7 29917 234.8 1 0.001
No 663 8.8 6838 91.2 7501 16 0.3 5997 99.7 6013
Total 19536 18.3 87274 81.7 106810 1310 3.6 34620 96.4 35930
Sore throat
Yes 4689 12.5 32844 87.5 37533 1.1 1 .283 279 3.0 9101 97.0 9380 104.2 1 0.001
No 849 12.0 6207 88.0 7056 24 0.5 5194 99.5 5218
Total 5538 12.4 39051 87.6 44589 303 2.1 14295 97.9 14598
Runny nose
Yes 1591 9.9 14478 90.1 16069 54.6 1 .001 109 2.9 3660 97.1 3769 78.7 1 0.001
No 922 13.2 6062 86.8 6984 29 0.6 5176 99.4 5205
Total 2513 10.9 20540 89.1 23053 138 1.5 8836 98.5 8974
Underlying diseases
Respiratory 22394 92.6 1780 7.4 24674 18793.9 5 0 806 7.5 9936 92.5 10742 171.1 5 .001
Cardiovascular 346 100.0 0 0.0 346 28 28.6 70 71.4 98
Renal 144 100.0 0 0.0 144 7 18.9 30 81.1 37
Malignancy 86 100.0 0 0.0 86 7 28.0 18 72.0 25
Hepatic 21 100.0 0 0.0 21 0 0.0 6 100 6
Other 1899 19.4 7898 80.6 9797 213 4.1 4966 95.9 5179
Total 24863 71.9 9678 28.1 34541 1061 6.6 15026 93.4 16087
Oxygen saturation (SpO2)
≤ 93 2417 50.8 2345 49.2 4762 3455.7 1 .001 283 19.1 1201 80.9 1484 0.373 1 .350
> 93 7966 15.9 42241 84.1 50207 352 2.2 16009 97.8 16361
Total 10383 18.9 44586 81.1 54969 635 3.6 17210 96.4 17845
Respiratory rate (breath/minute)
≤ 26 6522 17.7 30250 82.3 36772 309.9 1 .001 312 2.9 10187 97.1 10499 0.373 1 .350
> 26 586 34.8 1100 65.2 1686 7 4.4 159 95.6 166
Total 7108 18.5 31350 81.5 38458 319 3.0 10346 97.0 10665
Pneumonia diagnosis
Yes 6212 17.5 29247 82.5 35459 731.1 1 .001 233 2.8 8093 97.2 8326 27.3 1 1.67
No 28342 12.3 201575 87.7 229917 4479 1.9 221802 98.1 226281
Total 34554 13..0 230822 87.0 265376 4712 2.0 229895 98.0 234607
Severity score of pneumonia
>3 4218 14.8 24275 85.2 28493 739.9 1 .001 121 1.8 6538 98.2 6659 104.7 1 0.001
≤ 3 1994 28.6 4972 71.4 6966 112 6.7 1555 93.3 1667
Total 6212 17.5 29247 82.5 35459 233 7.5 8090 92.5 8326

3.8. Relationship between signs and symptoms and final outcome

Compared to asymptomatic cases, those who presented with fever or cough were associated with a higher than average rate of death (4.3% for each), with a fever of>39 °C having an even higher rate of death (6.1%). A low level of oxygen saturation (SpO2 ≤ 93%) was associated with a higher rate of death (19.1%) in comparison with SpO2 > 93%. Cases of COVID-19 with cardiovascular diseases or malignancy had the highest associations with death, 28.6% and 28% respectively, compared to other underlying diseases. Patients who were diagnosed with higher severity score of pneumonia (≥3) were associated with higher death rate (6.7%) compared to those with a lower pneumonia severity score (>3; 1.8%; P > .001) (Table 6).

4. Discussion

4.1. Distribution of COVID-19 cases in KSA

The Eastern, AlQassim, and Assir regions were the most affected regions, with a greater association of symptomatic cases. As large industrial and agricultural centres, and tourist attraction areas, there was likely higher traffic and movement of people in these regions, contributing to higher rates of COVID-19 infection compared to other regions. Furthermore, Makkah and Almadina, the two holy cities, had the highest CFRs. These regions have the highest proportion of Non-Saudis (Saudi General Authority for Statistics, 2018) primarily made up of illegal and low socio-economic residents seeking to be close to the two holy mosques. Fear of deportation contributes to illegal residents who become ill avoiding medical care in the health facilities unless their condition becomes severe.

The effect of nationality on acquiring COVID-19 was statistically minimal, however Arabs appeared to be more likely to be affected by COVID-19 than other nationalities. Since distribution based on ethnicity groups is ethically prohibited in KSA, this report cannot assess the effect of ethnicity on COVID-19. Foreign workers make up a significant portion (26%) of the population in KSA. There are significant numbers of Asian expatriates, mostly from India and Bangladesh, who were worst hit by COVID-19. Commonly, unlike Western expatriates, they live in shared and crowded dormitories where transmission of infection likely occurs much faster (Jackson and Manderscheid, 2015). Those who work in the private sector were more likely to contract COVID-19 than other occupations. Longer work periods and day & night shifts system in the private sector could play a role in this effect. By the end of July 2020, the number of new cases started to decrease remarkably, likely due to the earlier lockdown and ban on local and international travel.

4.2. Demographic characteristics of COVID-19 cases

Infection was most commonly observed in young adults. Previous studies have reported the age profile of infection was highest among those aged 20–29 years in the USA, China and Europe (Boehmer et al., 2020, Zhao et al., 2020, European Centre for Disease Prevention and Control, 2020). This age group consists of working-age adults, contributing to community transmission since COVID-19 can be easily transmitted among socially active people and in crowded settings. Given the role of asymptomatic and pre-symptomatic transmission, strict adherence to community mitigation strategies and personal preventive behaviours by young adults is needed to help reduce their risk for infection and subsequent transmission of COVID-19. This pandemic has shown a markedly low proportion of COVID-19 cases among children (Liu et al., 2020, Sun et al., 2020, Shim et al., 2020, CDC COVID-19 Response Team, 2020). This epidemiological feature contrasts with that of other respiratory infections, such as the 2009 influenza pandemic and H1N1pdm infection, where the cumulative incidence was highest among children and young adults, and much smaller among older adults (Van Kerkhove and Vandemaele, 2011, Badawi and Ryoo, 2016).

Similar to reports of MERS-COV and SARS-COV1, the male predominant culture of KSA and other Middle Eastern countries was likely reflected in the 2-fold higher number of males than females observed in the total COVID-19 positive cases (Channappanavar et al., 2017, Klein and Huber, 2009, Conti and Younes, 2020). Males are typically more involved in daily activities outside the home than females. Moreover, most females in KSA wear a veil, which could serve as a pseudo facemask. Finally, previous studies of MERS-CoV and SARS-CoV1 have suggested possible protective effect of female sex hormones and the X-chromosome (Channappanavar et al., 2017, Assiri et al., 2013).

4.3. Clinical and epidemiological characteristics

The clinical presentation of COVID-19 is similar to other flu-like illnesses, with fever appearing as predominant symptom worldwide. Fever is the cardinal symptom and the first indicator of COVID-19 infection, but a mild temperature (>38 Celsius)was present in the majority of symptomatic cases in this study. In the USA, it was reported that 44% of hospitalized COVID-19 patients did not have fever at the time of admission, but eventually 89% of them developed a high fever (CDC, 2020), therefore COVID-19 patients may present with normal or even low temperature upon hospital admission.

Cough, a symptom most commonly associated with respiratory infections, was the second most prevalent symptom among COVID-19 patients in KSA and worldwide (British Broadcasting Company, 2020). While sore throat and runny nose appear to be of less importance, all respiratory symptoms must be considered when screening for COVID-19 cases, among other epidemiological and clinical parameters. For instance, in the United Kingdom (UK), runny nose is a determinant for COVID-19 testing only if associated with a loss of smell (British Broadcasting Company, 2020).

In this study, most COVID-19 cases had a normal respiratory rate, typically measured when patients are dyspnoeic, or at the time of hospital admission. Therefore, it is assumed that all respiratory rate data were for hospitalized patients, explaining the relatively high mean respiratory rate (21.4 breaths/min) in this dataset. Shortness of breath typically appears 5–14 days after fever onset, and the degree of increase in respiration rate is proportionate to the severity of lung injury (Wu et al., 2020). The Saudi MoH defines a COVID-19 case as severe if respiration is ≥30 breaths/min (adult) or ≥40 breaths/min (child < 5) among other signs and symptoms (Saudi Weqaya & Ministry of Health, 2020).

SpO2 alone is not a reliable sign for COVID-19 screening, unless other respiratory symptoms and signs are also present (Saudi Weqaya & Ministry of Health, 2020) . Severe lung injury or pneumonia leads to a decrease in SpO2, however, in some cases, patients with low or even very low SpO2 have normal physical status. The available data about SpO2 in this study demonstrated that around 9% of symptomatic cases had SpO2 ≤ 93%. This result is relatively high but congruent with previous findings in KSA as well as in China, USA and UK (Alsofayan et al., 2020, European Centre for Disease Prevention and Control, 2020; Wu et al., 2020; Burrow et al., 2020).

Pneumonia with a confirmed positive PCR result for COVID-19 is not always an indication for hospital admission in KSA, especially during the outbreak peak ((Saudi Weqaya & Ministry of Health, 2020). Therefore, clinicians use a pneumonia severity score (vital signs, history of chronic diseases, demographics, comorbidities, physical exam, laboratory and radiological findings) to determine those who require hospitalization. This comprehensive score ranges from 1 to 5 with patients who score ≥ 3 qualifying for hospital admission (Burrow et al., 2020). While time consuming, it was conducted in some hospitals in KSA where 19.7% of pneumonia patients were deemed severe cases.

Hospital admission of COVID-19 cases in KSA was 13%, which is below the world average (15–20%) (Boehmer et al., 2020, European Centre for Disease Prevention and Control, 2020) and much lower than the rate was reported in KSA at the beginning of the pandemic (Alsofayan et al., 2020). Early active surveillance, case detection, case management, and most importantly a change in the case definition could have played a role in decreasing the rate of hospital admission.

Close contact to a confirmed COVID-19 case is the single-most important risk factor for contracting COVID-19 in KSA, confirming either direct or indirect transmission is possible through contaminated shared belongings. This finding confirms the importance of stipulating limited close contact with others during the pandemic, especially for those who would be at risk for severe illness.

4.4. Relationship between demographics and outcome of COVID-19 infection

Age demonstrated the highest and strongest association with the outcome of the COVID-19: as age increases, the chance of death increases. This finding has been reported worldwide during the COVID-19 pandemic, as well as in the previous MERS-CoV and SARS-CoV1 outbreaks (Boehmer et al., 2020, Badawi and Ryoo, 2016, Channappanavar et al., 2017, Onder et al., 2020). Generally, non-Saudis in KSA had an almost 2-fold higher association with mortality from COVID-19 than Saudis. Possible reasons behind this finding is the genetic differences, the lower socio-economic status, or the limited access to the health services. Further investigation is needed. Similar to reports from United States of America (USA) and UK which found those of African ethnicity had the highest mortality rate (Patel et al., 2020), Nigerians were more likely to die from COVID-19 than other nationalities in KSA.

In comparison to other regions of KSA, Makkah and Almadina had the highest association with death due to COVID-19. This result supports the earlier suggestion that the presence of a greater number of Non-Saudis of illegal residency and low socio-economic status, who fearing deportation, makes early access to the health services difficult. Patients who are labelled as freelancers and unemployed are more likely to die from COVID-19 than other occupations. This statistically significant result suggests that working in a formal and secured job could have a protective effect against serious complications of COVID-19, however this finding requires further exploration.

4.5. Relationship between sign & symptoms and final outcome of COVID-19 infection

Low oxygen saturation (SpO2 ≤ 93%) was the most important and critical indicator in predicting death associated with COVID-19 infection in KSA. Clinical studies at the beginning of the pandemic in China demonstrated that improving SpO2 with oxygen supplementation was associated with reduced mortality, independent of other factors (Xie et al., 2020). This study demonstrated that COVID-19 patients with higher body temperature (<39 Celsius) were 2-times likely to die than those with temperature 38 > Celsius. A previous report among COVID-19 patients found a significant increase in mortality for every 0.5 Celsius increase in temperature, and the mortality was as high as 42% in those with temperature 40 < Celsius. Nevertheless, a lower temperature at initial presentation is a marker of poor prognosis: mortality is 26.5% of those with a temperature ≤ 36 Celsius, and further increases (44.0%) with temperature ≤ 35.5 Celsius (Tharakan et al., 2020).

Patients who presented with severe pneumonia (severity score ≥ 3) are 3-fold more likely to die of COVID-19 infection than those with lower severity score. Acute respiratory distress syndrome of severe pneumonia is a common predictor of poor prognosis and is associated with a high rate of death in COVID-19 patients (Wu et al., 2020). Finally, chronic diseases have significant negative impact on the prognosis of COVID-19 patients. It is well documented that cardiovascular and respiratory diseases are related to the worst prognoses among COVID-19 patients (Boehmer et al., 2020, European Centre for Disease Prevention and Control, 2020, Liu et al., 2020, Wu and McGoogan, 2020). Likewise, this study demonstrated that cardiovascular diseases have the highest association with death among COVID-19 patients.

4.6. Relationship of demographics and symptoms with hospital admission of COVID-19 cases

The Northern Borders region had the highest association with hospital admission of COVID-19 patients in KSA. Northern Borders has a high hospital bed capacity relative to its small population. Likely, this availability of hospital beds made it possible for the doctors to admit mild to moderate COVID-19 cases, in addition to severe cases. A change in the case definition, different case management protocol, and the unique genetic factors of the virus or patients are among the other possible reasons for this high hospital admission rate. Oxygen saturation (SpO2 ≤ 93%) appears to be the most important determinant in hospital admission.

5. Limitations

First, there were limited details for the asymptomatic cases in HESN database to compare with the symptomatic cases. The registration process in HESN is lengthy and public health personnel focus on and enter the details of symptomatic cases more than that of asymptomatic cases. Second, the data set lacks sufficient information on the complications of the disease.

6. Conclusion

In KSA, COVID-19 was easily transmitted among young people who are socially active. Fever, cough, and sore throat were the prevalent symptoms consecutively. All regions are affected by the disease and inexplicably, the highest morbidity was distributed among the Eastern region, AlQassim and Assir respectively. However, Makkah and Almadina regions are significantly associated with highest burden of mortality. Low level of oxygen saturation, high fever, old age, and underlying cardiovascular disease are the most important predictors for the worst prognosis among COVID-19 cases.

CRediT authorship contribution statement

Fahad M. Alswaidi: Conceptualization, Methodology, Writing - original draft. Abdullah M. Assiri: Writing - review & editing. Haya H. Alhaqbani: Data curation, Formal analysis, Project administration. Mohrah M. Alalawi: Formal analysis, Writing - original draft.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

Acknowledgements

We are thankful to our colleagues in the health electronic surveillance system (HESN) for their support in providing the raw data of this study.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data availability statement

The data underlying this article cannot be shared publicly due to the non-disclosure agreement between the Saudi MOH and the authors. The data will be shared on reasonable request to the corresponding author.

Footnotes

Peer review under responsibility of King Saud University.

Contributor Information

Fahad M. Alswaidi, Email: falswaidi@moh.gov.sa.

Abdullah M. Assiri, Email: AbdullahM.Asiri@moh.gov.sa.

Haya H. Alhaqbani, Email: halhaqbani@moh.gov.sa.

Mohrah M. Alalawi, Email: Malalwy@moh.gov.sa.

References

  1. Alkhowailed M., Shariq A., Alqossayir F., Alzahrani O.A., Rasheed Z., Abdulmonem W.A. Impact of meteorological parameters on COVID-19 pandemic: a comprehensive study from Saudi Arabia. Inf. Med. Unlocked. 2020;20:100418. doi: 10.1016/j.imu.2020.100418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Almaghlouth I., Islam T., Alamro N. Mapping COVID-19 related research from Saudi Arabia, a scoping review. Between reality and dreams. Saudi Med. J. 2020;41:791–801. doi: 10.15537/smj.2020.8.25163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alsofayan Y.M., Althunayyan S.M., Khan A.A., Hakawi A.M., Assiri A.M. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J. Infect. Publ. Health. 2020;13:920–925. doi: 10.1016/j.jiph.2020.05.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Al-Tawfiq J.A., Memish Z.A. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies. Int. J. Antimicrob. Agents. 2020;55:105968. doi: 10.1016/j.ijantimicag.2020.105968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet. Infect. Dis. 2013;13:752–761. doi: 10.1016/S1473-3099(13)70204-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Badawi A., Ryoo S.G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int. J. Infect. Dis. 2016;49:129–133. doi: 10.1016/j.ijid.2016.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boehmer, T.K. et al., 2020. Changing age distribution of the COVID-19 Pandemic— United States, May–August 2020. MMWR Morb. Mortal. Wkly. Rep., 2020 Sep 23; [e-pub]. 10.15585/mmwr.mm6939e1. [DOI] [PMC free article] [PubMed]
  8. British Broadcasting Company, 2020. Covid19 symptoms: Is it a cold, flu or coronavirus? [cited 2020 Sep 14]. Available from: https://www.bbc.com/news/health-54145299.
  9. Burrow, R., Treadwell, J., Roberts, N., 2020. What clinical features or scoring system, if any, might best predict a benefit from hospital admission for patients with COVID-19? 2020. [cited 2020 Sep 29]. Available from: https://www.cebm.net/covid-19/what-clinical-features-or-scoring-system-if-any-might-best-predict-a-benefit-from-hospital-admission-for-patients-with-covid-19/.
  10. CDC COVID-19 Response Team Coronavirus Disease 20*19 in Children - United States. MMWR Morb. Mortal. Wkly. Rep. 2020;69(14):422–426. doi: 10.15585/mmwr.mm6914e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Centers for Disease Control, 2008. Principles of Epidemiology 2008. [cited 2020 Oct 14]. Available from: http://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson3/section2.html.
  12. Centers of Disease Control, 2020. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19), Oct 2020. [cited 2020 Oct 30]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
  13. Channappanavar R., Fett C., Mack M., Ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J. Immunol. 2017;198(10):4046–4053. doi: 10.4049/jimmunol.1601896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). [cited 2020 Oct 30]. Available from: https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.
  15. Conti P., Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J. Biol. Regul. Homeost. Agents. 2020;34(2):71. doi: 10.23812/Editorial-Conti-3. [DOI] [PubMed] [Google Scholar]
  16. COVID-19 dashboard, Saudi Arabia, 2020. [cited 2020 Oct 30]. Available from: https://covid19.moh.gov.sa.
  17. European Centre for Disease Prevention and Control, 2020. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK–eleventh update: resurgence of cases. [cited 2020 Oct 30]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-20200810.pdf.
  18. Harmooshi N.N., Shirbandi K., Rahim F. Environmental concern regarding the effect of humidity and temperature on 2019-nCoV survival: fact or fiction. Environ. Sci. Pollut. Res. 2020;27:26027–26036. doi: 10.1007/s11356-020-09733-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hossain I., Khan M.H., Rahman M.S., Mullick A.R., Aktaruzzaman M.M. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in Bangladesh: a descriptive study. J. Med. Sci. Clin. Res. 2020;8(04) [Google Scholar]
  20. Jackson D., Manderscheid S.V. A phenomenological study of Western expatriates’ adjustment to Saudi Arabia. Hum. Resour. Develop. Int. 2015;18:131–152. [Google Scholar]
  21. Jdaitawi M., Jdaitawi L., Alkurdi R. Analyzing the spread of COVID-19 in Saudi Arabia and controlling disease strategies. Int. J. Int. Emerg. Med. 2020;3:1028. [Google Scholar]
  22. Klein S.L., Huber S. Sex differences in susceptibility to viral infection. In: Klein S.L., Roberts C.W., editors. Sex Hormones and Immunity to Infection. Springer-Verlag; Berlin: 2009. [Google Scholar]
  23. Liu Z., Bing X., Zhi X.Z. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Epidemiology Working Group for NCIP Epidemic Response. Chin. Center Dis. Control Prevent. 2020;41:145–151. [Google Scholar]
  24. Onder G., Rezza G., Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323:1775–1776. doi: 10.1001/jama.2020.4683. [DOI] [PubMed] [Google Scholar]
  25. Patel P., Hiam L., Sowemimo A., Devakumar D., McKee M. Ethnicity and covid-19. BMJ. 2020;369 doi: 10.1136/bmj.m2282. [DOI] [PubMed] [Google Scholar]
  26. Saudi General Authority for Statistics, 2018. Population & Demography. [cited 2020 Nov 29]. Available from: https://www.stats.gov.sa/en/1007-0.
  27. Saudi Weqaya & Ministry of Health, 2020. COVID-19 Coronavirus Disease Guidelines (V. 1. 3). [cited 2020 Oct 15]. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Coronavirus-Disease-2019-Guidelines-v1.2.pdf.
  28. Shim E., Tariq A., Choi W., Lee Y., Chowell G. Transmission potential and severity of COVID-19 in South Korea. Int. J. Infect. Dis. 2020;93:339–344. doi: 10.1016/j.ijid.2020.03.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Singhal T. A review of coronavirus disease-2019 (COVID-19) Indian J. Pediat. 2020;87:281–286. doi: 10.1007/s12098-020-03263-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sun K., Chen J., Viboud C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet Digit. Health. 2020;2:e201–e208. doi: 10.1016/S2589-7500(20)30026-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tharakan S., Nomoto K., Miyashita S. Body temperature correlates with mortality in COVID-19 patients. Crit. Care. 2020;2020(24):298. doi: 10.1186/s13054-020-03045-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Van Kerkhove M.D., Vandemaele K.A. Shinde V et al Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053. doi: 10.1371/journal.pmed.1001053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wu C., Chen X., Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Int. Med. 2020;180(7):934–943. doi: 10.1001/jamainternmed.2020.0994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wu Z., McGoogan J.M. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648. [DOI] [PubMed] [Google Scholar]
  35. Xie J., Covassin N., Fan Z. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin. Proc. 2020;95:1138–1147. doi: 10.1016/j.mayocp.2020.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Youssef H.M., Alghamdi N.A., Ezzat M.A., El-Bary A.A., Shawky A.M. A modified SEIR model applied to the data of COVID-19 spread in Saudi Arabia. AIP Adv. 2020;10:125210. doi: 10.1063/5.0029698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Youssef H.M., Alghamdi N.A., Ezzat M.A., El-Bary A.A., Shawky A.M. A new dynamical modeling SEIR with global analysis applied to the real data of spreading COVID-19 in Saudi Arabia. Math. Biosci. Eng. 2020;17(6) doi: 10.3934/mbe.2020362. [DOI] [PubMed] [Google Scholar]
  38. Zhao W., Zhong Z., Xie X., Yu Q., Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. Am. J. Roentgenol. 2020;214:1072–1077. doi: 10.2214/AJR.20.22976. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data underlying this article cannot be shared publicly due to the non-disclosure agreement between the Saudi MOH and the authors. The data will be shared on reasonable request to the corresponding author.


Articles from Saudi Pharmaceutical Journal : SPJ are provided here courtesy of Springer

RESOURCES